High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 42, Issue 7, 1999, Pages 1458-1465

  Kammer, Gary M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ANTIGENICITY; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE ACTIVITY; ENZYME DEFICIENCY; FEMALE; HELPER CELL; HUMAN; KILLER CELL; MALE; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ADULT; CHILD; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; HUMANS; ISOENZYMES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; TIME FACTORS;

EID: 0033509782     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199907)42:7<1458::AID-ANR20>3.0.CO;2-P     Document Type: Article

References (46)

1. Horwitz DA, Stohl W, Gray JD. T lymphocytes, natural killer cells, cytokines, and immune regulation. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. Baltimore: Williams & Wilkins; 1997. p. 155-94.
2. Putterman C, Kuo P, Diamond B. The structure and derivation of antibodies and autoantibodies. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. Baltimore: Williams & Wilkins; 1997. p. 383-96.
3. Hagiwara E, Gourley MF, Lee S, Klinman DM. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum 1996;39:379-85.
4. Desai-Mehta A, Lu LJ, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996;97: 2063-73.
5. Koshy M, Berger D, Crow MK. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 1996;98:826-37.
6. Richardson B, Powers D, Hooper F, Yung RL, O'Rourke K. Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum 1994;37:1363-72.
7. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus: a putative role in pathogenesis. J Immunol 1991;147:117-23.
8. Klinman DM, Steinberg AD. Inquiry into murine and human lupus. Immunol Rev 1995;144:157-93.
9. Shores EW, Eisenberg RA, Cohen PL. Role of the Sm antigen in the generation of anti-Sm autoantibodies in the SLE-prone MRL mouse. J Immunol 1986;136:3662-7.
10. Singh RR, Hahn BH, Tsao BP, Ebling FM. Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus. J Clin Invest 1998;102:1841-9.
11. Shi Y, Kaliyaperumal A, Lu LJ, Southwood S, Sette A, Michaels MA, et al. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor α chain. J Exp Med 1998;187:367-78.
12. Kammer GM, Birch RE, Polmar S. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation. J Immunol 1983;130:1706-12.
13. Ohtsuka K, Gray JD, Stimmler MM, Toro B, Horwitz DA. Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus. J Immunol 1998;160:2539-45.
14. Madaio MP. B cells and autoantibodies in the pathogenesis of lupus nephritis. Immunol Res 1998;17:123-32.
15. Dayal AK, Kammer GM. The T cell enigma in lupus. Arthritis Rheum 1996;39:23-33.
16. Kammer GM. Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus: evidence for a disorder intrinsic to the T lymphocyte. J Clin Invest 1983;72:1686-97.
17. Mandler R, Birch RE, Polmar S, Kammer GM, Rudolph SA. Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A 1982;79:7542-6.
18. Hasler P, Schultz LA, Kammer GM. Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus. Proc Natl Acad Sci U S A 1990;87:1978-82.
19. Kammer GM, Khan IU, Malemud CJ. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J Clin Invest 1994;94:422-30.
20. Kammer GM, Khan IU, Kammer JA, Olorenshaw I, Mathis D. Deficient type I protein kinase A activity in systemic lupus erythematosus T lymphocytes. II. Abnormal isozyme kinetics. J Immunol 1996;157:2690-8.
21. Kammer GM. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 1988;9:222-9.
22. Krebs EG, Beavo JA. Phosphorylation-dephosphorylation of enzymes. Annu Rev Biochem 1979;48:923-39.
23. Taylor SS, Buechler JA, Yonemoto W. cAMP-dependent protein kinase: framework for a diverse family of regulatory subunits. Annu Rev Biochem 1990;59:971-1005.
24. Taskén K, Skålhegg BS, Taskén KA, Solberg R, Knutsen HK, Levy FO, et al. Structure, function, and regulation of human cAMP-dependent protein kinases. Adv Second Messenger Phosphoprotein Res 1997;31:191-204.
25. Hasler P, Moore JJ, Kammer GM. Human T lymphocyte cAMP-dependent protein kinase: subcellular distributions and activity ranges of type I and type II isozymes. FASEB J 1992;6:2735-41.
26. Laxminarayana D, Berrada A, Kammer GM. Early events of human T lymphocyte activation are associated with type I protein kinase A activity. J Clin Invest 1993;92:2207-14.
27. Laxminarayana D, Kammer GM. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation. J Immunol 1996;156:497-506.
28. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
29. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
30. Hawker G, Gabriel S, Bombardier C, Goldsmith C, Caron D, Gladman D. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. J Rheumatol 1993;20:657-60.
31. Inghirami G, Simon J, Balow JE, Tsokos GC. Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin. Clin Exp Rheumatol 1988;6:269-76.
32. Khan IU, Laxminarayana D, Mishra N, Clerenshaw I, Tasken K, Kammer GM. Diminished levels of protein kinase A RIα and RIβ transcripts and proteins in systemic lupus erythematosus T lymphocytes. J Immunol 1999;162:5639-48.
33. Boshart M, Weih F, Nichols M, Schutz G. The tissue-specific extinguisher locus TSE1 encodes a regulatory subunit of cAMP-dependent protein kinase. Cell 1991;66:849-59.
34. Solberg R, Sistonen P, Traskelin AL, Berube D, Simard J, Krajci P, et al. Mapping of the regulatory subunits RIβ and RIIβ of cAMP-dependent protein kinase genes on human chromosome 7. Genomics 1992;14:63-9.
35. Khan IU, Wallin R, Gupta RS, Kammer GM. Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane. Proc Natl Acad Sci U S A 1998;95:10425-30.
36. Rooney JW, Sun Y-L, Glimcher LH, Hoey T. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol 1995;15:6299-310.
37. Fisch TM, Prywes R, Simon MC, Roeder RG. Multiple sequence elements in the c-fos promoter mediate induction by cAMP. Genes Dev 1989;3:198-211.
38. Yamamoto KK, Gonzalez GA, Biggs WH III, Montminy MR. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 1988;334:494-8.
39. Chrivia JC, Kwok RSP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993;365:855-9.
40. Kwok RSP, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994;370:223-6.
41. Brindle P, Nakajima T, Montminy MR. Multiple protein kinase A-regulated events are required for transcriptional induction by cAMP. Proc Natl Acad Sci U S A 1995;92:10521-5.
42. Parker D, Ferreri K, Nakajima T, LaMorte VJ, Evans R, Koerber SC, et al. Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol 1996;16:694-703.
43. Kee BL, Arias J, Montminy MR. Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator. J Biol Chem 1996;271:2373-5.
44. Loriaux MM, Rehfuss RP, Brennan RG, Goodman RH. Engineered leucine zippers show that hemiphosphorylated CREB complexes are transcriptionally active. Proc Natl Acad Sci U S A 1993;90:9046-50.
45. Becker H, Stengl G, Stein M, Federlin K. Analysis of proteins that interact with the IL-2 regulatory region in patients with rheumatic diseases. Clin Exp Immunol 1995;99:325-30.
46. Alcocer-Varela J, Alarcón-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 1982;69: 1388-92.